Display options
Share it on

Hepatol Int. 2014 Sep;8:432-8. doi: 10.1007/s12072-013-9511-7. Epub 2013 Dec 29.

Hepatocyte-mediated cytotoxicity and host defense mechanisms in the alcohol-injured liver.

Hepatology international

Benita L McVicker, Geoffrey M Thiele, Dean J Tuma, Carol A Casey

Affiliations

  1. Research Service (151), VA Nebraska-Western Iowa Health Care System, 4101 Woolworth Avenue (151), Omaha, NE, 68105, USA. [email protected].
  2. Department of Internal Medicine, University of Nebraska Medical Center, 982000 Nebraska Medical Center, Omaha, NE, 68198-2000, USA. [email protected].
  3. Research Service (151), VA Nebraska-Western Iowa Health Care System, 4101 Woolworth Avenue (151), Omaha, NE, 68105, USA.
  4. Department of Internal Medicine, University of Nebraska Medical Center, 982000 Nebraska Medical Center, Omaha, NE, 68198-2000, USA.
  5. Department of Pathology and Microbiology, University of Nebraska Medical Center, 985870 Nebraska Medical Center, Omaha, NE, 68198-5870, USA.
  6. Department of Biochemistry & Molecular Biology, University of Nebraska Medical Center, 985870 Nebraska Medical Center, Omaha, NE, 68198-5870, USA.

PMID: 26201322 DOI: 10.1007/s12072-013-9511-7

Abstract

The consumption of alcohol is associated with many health issues including alcoholic liver disease (ALD). The natural history of ALD involves the development of steatosis, inflammation (steatohepatitis), fibrosis and cirrhosis. During the stage of steatohepatitis, the combination of inflammation and cellular damage can progress to a severe condition termed alcoholic hepatitis (AH). Unfortunately, the pathogenesis of AH remains uncharacterized. Some modulations have been identified in host defense and liver immunity mechanisms during AH that highlight the role of intrahepatic lymphocyte accumulation and associated inflammatory cytokine responses. Also, it is hypothesized that alcohol-induced injury to liver cells may significantly contribute to the aberrant lymphocytic distribution that is seen in AH. In particular, the regulation of lymphocytes by hepatocytes may be disrupted in the alcoholic liver resulting in altered immunologic homeostasis and perpetuation of disease. In recent studies, it was demonstrated that the direct killing of activated T lymphocytes by hepatocytes is facilitated by the asialoglycoprotein receptor (ASGPR). The ASGPR is a well-characterized glycoprotein receptor that is exclusively expressed by hepatocytes. This hepatic receptor is known for its role in the clearance of desialylated glycoproteins or cells, yet neither its physiological function nor its role in disease states has been determined. Interestingly, alcohol markedly impairs ASGPR function; however, the effect alcohol has on ASGPR-mediated cytotoxicity of lymphocytes remains to be elucidated. This review discusses the contribution of hepatocytes in immunological regulation and, importantly, how pathological effects of ethanol disrupt hepatocellular-mediated defense mechanisms.

Keywords: Alcoholic hepatitis; Alcoholic liver disease; Asialoglycoprotein receptor; Intrahepatic lymphocytes; Receptor-mediated endocytosis

References

  1. Alcohol Clin Exp Res. 1989 Apr;13(2):258-63 - PubMed
  2. Cell Immunol. 1984 Oct 15;88(2):309-22 - PubMed
  3. J Immunol. 2001 Jul 15;167(2):667-73 - PubMed
  4. Hepatology. 2011 Sep 2;54(3):1043-50 - PubMed
  5. Genes Nutr. 2010 Jun;5(2):141-7 - PubMed
  6. Front Biosci. 2005 Sep 01;10:3093-9 - PubMed
  7. Int Immunopharmacol. 2013 May;16(1):17-26 - PubMed
  8. Front Biosci. 2002 Mar 01;7:d717-25 - PubMed
  9. Toxicol Mech Methods. 2007;17(7):431-40 - PubMed
  10. Alcohol Clin Exp Res. 1998 May;22(3):723-9 - PubMed
  11. Immunol Rev. 2000 Apr;174:21-34 - PubMed
  12. Mol Immunol. 1985 Aug;22(8):887-92 - PubMed
  13. Alcohol Alcohol Suppl. 1991;1:297-303 - PubMed
  14. Hepatology. 2008 May;47(5):1691-701 - PubMed
  15. Gastroenterology. 1999 Oct;117(4):942-52 - PubMed
  16. JAMA. 1981 Nov 20;246(20):2358-64 - PubMed
  17. Trends Immunol. 2008 Feb;29(2):83-90 - PubMed
  18. Alcohol Clin Exp Res. 1999 Jul;23(7):1207-9 - PubMed
  19. J Biol Chem. 1987 Feb 25;262(6):2704-10 - PubMed
  20. Hepatology. 2002 Dec;36(6):1478-87 - PubMed
  21. J Clin Immunol. 1991 Sep;11(5):246-53 - PubMed
  22. Eur J Histochem. 2000;44(3):217-27 - PubMed
  23. FASEB J. 2001 Jun;15(8):1335-49 - PubMed
  24. Nat Med. 2008 Jun;14(6):648-55 - PubMed
  25. J Clin Invest. 2005 Feb;115(2):209-18 - PubMed
  26. Hepatology. 2009 Apr;49(4):1326-34 - PubMed
  27. Semin Liver Dis. 2004 Aug;24(3):273-87 - PubMed
  28. Hepatology. 2009 Aug;50(2):638-44 - PubMed
  29. Proc Natl Acad Sci U S A. 2011 Oct 4;108(40):16735-40 - PubMed
  30. Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17125-9 - PubMed
  31. J Biol Chem. 1996 Feb 2;271(5):2531-8 - PubMed
  32. Alcohol. 1999 Nov;19(3):255-60 - PubMed
  33. Immunol Rev. 2000 Apr;174:47-62 - PubMed
  34. Gastroenterology. 2010 Aug;139(2):664-74, 674.e1 - PubMed
  35. Alcohol Clin Exp Res. 2007 Jan;31(1):122-9 - PubMed
  36. Gastroenterology. 2011 Nov;141(5):1572-85 - PubMed
  37. Int J Hepatol. 2012;2012:893026 - PubMed
  38. Immunol Cell Biol. 2002 Feb;80(1):74-83 - PubMed
  39. Biochem Biophys Res Commun. 1993 Sep 15;195(2):1127-33 - PubMed
  40. Front Biosci. 2002 Jul 1;7:d1662-75 - PubMed
  41. Am J Gastroenterol. 1993 Nov;88(11):1920-7 - PubMed
  42. J Virol. 2003 Jan;77(1):546-59 - PubMed
  43. Eur J Immunol. 2006 Jul;36(7):1654-8 - PubMed
  44. Immunol Rev. 2006 Oct;213:101-18 - PubMed
  45. J Dig Dis. 2011 Feb;12(1):17-24 - PubMed
  46. Hepatology. 2006 Jun;43(6):1231-40 - PubMed
  47. J Leukoc Biol. 2007 Jan;81(1):284-96 - PubMed

Publication Types

Grant support